Dual ACE2 epitope-based biomimetic receptors for selective sensing of SARS-CoV variants.

Dual ACE2 epitope-based biomimetic receptors for selective sensing of SARS-CoV variants.

Publication date: Sep 23, 2025

We report a combinatorial approach to design peptide-based biomimetic sensors for detecting β-type coronaviruses with high sensitivity and selectivity. We selected three peptide epitopes from key regions of the ACE2 receptor that are involved in viral binding to different variants and immobilized them individually or in binary combinations on gold sensor chips. Using Surface Plasmon Resonance (SPR), we found that single-epitope sensors displayed nanomolar dissociation constants to three RBD variants (SARS-CoV-2 Delta 

Open Access PDF

Concepts Keywords
Combinatorial ACE2 protein, human
Coronaviruses ACE2-based sensor
Immobilized Angiotensin-Converting Enzyme 2
Nanomolar Angiotensin-Converting Enzyme 2
Proteins Betacoronavirus
Biomimetics
Biosensing Techniques
Biosensor
Combinatorial detection
COVID-19
Epitopes
Epitopes
Humans
Molecular Dynamics Simulation
Protein Binding
SARS-CoV variants
SARS-CoV-2
SARS-CoV-2
Spike Glycoprotein, Coronavirus
Spike Glycoprotein, Coronavirus
spike protein, SARS-CoV-2
SPR
Surface Plasmon Resonance

Semantics

Type Source Name
drug DRUGBANK Gold
disease MESH dissociation
disease IDO infectivity
disease MESH immobilization
drug DRUGBANK Coenzyme M
disease IDO protein
drug DRUGBANK Acetate ion
drug DRUGBANK Aspartame
disease MESH COVID-19

Original Article

(Visited 5 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *